These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method. Oltulu O, Yaşar MM, Eroğlu E. Eur J Med Chem; 2009 Sep; 44(9):3439-44. PubMed ID: 19303173 [Abstract] [Full Text] [Related]
5. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes. Deeb O, Goodarzi M, Khadikar PV. Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786 [Abstract] [Full Text] [Related]
6. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Supuran CT. Bioorg Med Chem; 2006 Feb 15; 14(4):1108-14. PubMed ID: 16213737 [Abstract] [Full Text] [Related]
7. QSAR study on benzenesulphonamide carbonic anhydrase inhibitors: topological approach using Balaban index. Thakur A, Thakur M, Khadikar PV, Supuran CT, Sudele P. Bioorg Med Chem; 2004 Feb 15; 12(4):789-93. PubMed ID: 14759739 [Abstract] [Full Text] [Related]
11. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT. Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481 [Abstract] [Full Text] [Related]
12. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Ozensoy O, Nishimori I, Vullo D, Puccetti L, Scozzafava A, Supuran CT. Bioorg Med Chem; 2005 Nov 15; 13(22):6089-93. PubMed ID: 16006130 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A, Kaila K, Supuran CT. Bioorg Med Chem Lett; 2005 Feb 15; 15(4):971-6. PubMed ID: 15686895 [Abstract] [Full Text] [Related]
14. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors. Sethi KK, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P. Bioorg Med Chem Lett; 2010 May 15; 20(10):3089-93. PubMed ID: 20443227 [Abstract] [Full Text] [Related]
16. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. Thiry A, Ledecq M, Cecchi A, Dogné JM, Wouters J, Supuran CT, Masereel B. J Med Chem; 2006 May 04; 49(9):2743-9. PubMed ID: 16640335 [Abstract] [Full Text] [Related]
20. Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides. Jaiswal M, Khadikar PV, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3283-90. PubMed ID: 15149691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]